CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-31 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −11,694 | 152,027 | ||
| 2025-10-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +11,694 | 179,786 | ||
| 2025-10-31 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −11,694 | 152,027 | ||
| 2025-10-31 | Collard Craig A Chief Executive Officer | Option exercise | +34,789 | 523,124 | ||
| 2025-10-31 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −34,789 | 452,253 | ||
| 2025-10-19 | Forbes William P EVP, Chief Development Officer | Option exercise | +3,874 | 154,509 | ||
| 2025-10-19 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −3,874 | 34,869 | ||
| 2025-10-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise | +3,874 | 168,092 | ||
| 2025-10-19 | Duarte Ira EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −3,874 | 34,869 | ||
| 2025-10-19 | Collard Craig A Chief Executive Officer | Option exercise | +13,797 | 488,335 | ||
| 2025-10-19 | Collard Craig A Chief Executive Officer | Option exercise · Restricted Stock Units | −13,797 | 124,172 | ||
| 2025-10-15 | Rubric Capital Management LP 10% owner | Conversion | +946,100 | 30,046,828 | ||
| 2025-10-15 | Rubric Capital Management LP 10% owner | Conversion · Series A Convertible Preferred Stock ("Preferred Shares") | −94,610 | 0 | ||
| 2025-08-08 | Morgan Adam Director | Purchase | +1,766,546 | $1.50 | $2.6M | 8,753,290 |
| 2025-08-08 | Morgan Adam Director | Purchase · Series A Convertible Preferred Stock | +70,012 | $15.00 | $1.1M | 70,012 |
| 2025-08-08 | Rubric Capital Management LP 10% owner | Purchase | +2,387,225 | $1.50 | $3.6M | 29,100,728 |
| 2025-08-08 | Rubric Capital Management LP 10% owner | Purchase · Convertible Senior Unsecured Promissory Notes ("Notes") | +0 | $33,250,000.00 | $0 | |
| 2025-08-08 | Rubric Capital Management LP 10% owner | Purchase · Series A Convertible Preferred Stock ("Preferred Shares") | +94,610 | $15.00 | $1.4M | 94,610 |
| 2025-07-31 | Forbes William P EVP, Chief Development Officer | Option exercise | +11,695 | 150,635 | ||
| 2025-07-31 | Forbes William P EVP, Chief Development Officer | Option exercise · Restricted Stock Units | −11,695 | 163,721 |
Page 7 of 28 · 557 trades